Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small a… Read more
Bioqual Inc (BIOQ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: -0.059x
Based on the latest financial reports, Bioqual Inc (BIOQ) has a cash flow conversion efficiency ratio of -0.059x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.12 Million) by net assets ($35.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioqual Inc - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Bioqual Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioqual Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioqual Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lucent, Inc.
OTCQB:LUCN
|
18.398x |
|
FatPipe, Inc. Common Stock
NASDAQ:FATN
|
0.011x |
|
TAFI Industries Bhd
KLSE:7211
|
-0.045x |
|
Coal Energy S.A.
WAR:CLE
|
0.080x |
|
US NeuroSurgical Holdings Inc
PINK:USNU
|
-0.088x |
|
Harbor Bankshares Corporation
PINK:HRBK
|
0.054x |
|
HASS Corp
KQ:450330
|
-0.003x |
|
Aplisens SA
WAR:APN
|
0.047x |
Annual Cash Flow Conversion Efficiency for Bioqual Inc (1996–2025)
The table below shows the annual cash flow conversion efficiency of Bioqual Inc from 1996 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $36.15 Million | $2.94 Million | 0.081x | -67.23% |
| 2024-05-31 | $37.65 Million | $9.36 Million | 0.249x | +13.61% |
| 2023-05-31 | $37.61 Million | $8.23 Million | 0.219x | +2530.45% |
| 2022-05-31 | $37.67 Million | $313.36K | 0.008x | -87.01% |
| 2021-05-31 | $33.53 Million | $2.15 Million | 0.064x | -55.77% |
| 2020-05-31 | $28.18 Million | $4.08 Million | 0.145x | +109.39% |
| 2019-05-31 | $24.56 Million | $1.70 Million | 0.069x | -58.89% |
| 2018-05-31 | $22.05 Million | $3.71 Million | 0.168x | -41.04% |
| 2017-05-31 | $18.92 Million | $5.39 Million | 0.285x | +73.90% |
| 2016-05-31 | $15.35 Million | $2.52 Million | 0.164x | -15.04% |
| 2015-05-31 | $12.79 Million | $2.47 Million | 0.193x | +392.37% |
| 2014-05-31 | $11.06 Million | $-730.26K | -0.066x | -1497.94% |
| 2013-05-31 | $10.34 Million | $48.84K | 0.005x | -77.67% |
| 2011-05-31 | $10.37 Million | $219.39K | 0.021x | -68.76% |
| 2010-05-31 | $10.16 Million | $688.18K | 0.068x | -66.45% |
| 2007-05-31 | $7.64 Million | $1.54 Million | 0.202x | -27.62% |
| 2006-05-31 | $6.65 Million | $1.85 Million | 0.279x | -28.59% |
| 2005-05-31 | $6.24 Million | $2.44 Million | 0.391x | +159.14% |
| 2004-05-31 | $5.51 Million | $829.76K | 0.151x | -60.70% |
| 2003-05-31 | $4.75 Million | $1.82 Million | 0.383x | +72.26% |
| 2001-05-31 | $3.83 Million | $852.40K | 0.223x | +808.82% |
| 2000-05-31 | $3.57 Million | $-112.06K | -0.031x | -128.72% |
| 1999-05-31 | $3.50 Million | $382.27K | 0.109x | -48.05% |
| 1998-05-31 | $3.16 Million | $664.77K | 0.210x | +716.40% |
| 1997-05-31 | $3.31 Million | $-112.97K | -0.034x | -127.81% |
| 1996-05-31 | $3.30 Million | $405.70K | 0.123x | -- |